Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix to Market NimbleGen Custom Arrays: Jun 22, 2004 (rev. 1)

NEW YORK, June 22 (GenomeWeb News) -Affymetrix will commercialize NimbleGen's customized microarrays, NimbleGen said today.

 

Under the agreement, Affymetrix will offer its customers made-to-order versions of the NimbleExpress array for use on the Affymetrix GeneChip instrument systems. Customers will be required to place a minimum order of 10 arrays, and there will be a four-week lead time on orders, NimbleGen said.

 

The NimbleExpress array is made using a maskless photolithography, enabling greater flexibility in design than the photolithography masks on traditional Affymetrix arrays.

 

The arrays can interrogate up to 12,000 transcripts for gene expression experiments, and can also be used for genome tiling and other experiments, NimbleGen said.

 

NimbleGen is based in Madison, Wis.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.